Search

Jacques F Banchereau

from Montclair, NJ
Age ~71
Get Report
Also known as:
Jacques Francois Banchereau, Jaques F Banchereau, Jacq Banchereau, Jacques Branchereau
Phone and address:
126 Lloyd Rd, Montclair, NJ 07042
(973) 707-2029
Related to:
Francois Banchereau Romain, 41Banchereau Romain, 41
Connected to:
John E Banchero, 46Linda A Banchini, 55Yollianne Banchs, 54Mary B Banciella, 59Pilar Bancilhon, 60Mircea Banciu, 104Bryan J Banck, 44Carole Bancroft, 81Caroline J Bancroft, 63Dave C Bancroft

Jacques Banchereau Phones & Addresses

    s
  • 126 Lloyd Rd, Montclair, NJ 07042 (973) 707-2029
  • Farmington, CT
  • 6730 Northaven Rd, Dallas, TX 75230 (214) 739-8580
  • 2752 Gaston Ave, Dallas, TX 75226 (214) 748-0562
  • Clifton, NJ
  • San Francisco, CA
  • 126 Lloyd Rd, Montclair, NJ 07042 (214) 454-7976

Work

Company: Université paris 13 2014 Position: Professor of clinical immunology

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Université Claude Bernard Lyon 1 1993 to 1993 Specialities: Philosophy

Languages

English • French

Industries

Biotechnology

Resumes

Resumes

Jacques Banchereau Photo 1

Professor Of Clinical Immunology

View page
Location:
126 Lloyd Rd, Montclair, NJ 07042
Industry:
Biotechnology
Work:
Université Paris 13
Professor of Clinical Immunology
The Jackson Laboratory
Professor, Director of Immunological Sciences, Deputy Director
Icahn School of Medicine at Mount Sinai
Adjunct Professor
Baylor College of Dentistry
Adjunct Professor
Baylor University
Adjunct Professor
Education:
Université Claude Bernard Lyon 1 1993 - 1993
Doctorates, Doctor of Philosophy, Philosophy Université Paris - Sorbonne 1980
Doctorates, Doctor of Philosophy, Biochemistry, Philosophy University of Paris I: Panthéon - Sorbonne 1980 - 1980
Doctorates, Doctor of Philosophy, Biochemistry, Philosophy Faculté De Droit, D’économie Et De Gestion De L'université D'angers 1975 - 1975
Bachelors, Bachelor of Science, Pharmacy
Languages:
English
French

Business Records

Name / Title
Company / Classification
Phones & Addresses
Jacques B. Banchereau
Director
The Baylor Research Institute
Noncommercial Research Organization
3434 Live Oak St, Dallas, TX 75204
Jacques Banchereau
Governing
JACQUES BANCHEREAU CONSULTING, LLC
50 Frst Hl Dr, Farmington, CT 06032
Jacques Banchereau
Director, Governing PersonSole
Jacques Banchereau Consulting LLC
Business Consulting Services
126 Lloyd Rd, Montclair, NJ 07042

Publications

Us Patents

Isolated Mammalian Dendritic Cell Genes; Related Reagents

View page
US Patent:
6361939, Mar 26, 2002
Filed:
Nov 25, 1997
Appl. No.:
08/978289
Inventors:
Elizabeth Esther Mary Bates - Lyons, FR
Blandine Marie de Saint-Vis - Lyons, FR
Christophe Caux - Lyons, FR
Serge J. E. Lebecque - Civrieux dAzergue, FR
Jacques Banchereau - Dallas TX
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07H 2104
US Classification:
435 6, 435 691, 43525233, 4353201, 435325, 435366, 435975, 530350, 536 235
Abstract:
Polynucleotides encoding various dendritic cell specific proteins from a primate are provided. Uses of purified sequences are also disclosed, including producing related reagents, e. g. , specific antibodies, and purified proteins. Methods of using these reagents and related diagnostic kits are also described.

Mammalian Dendritic Cell Chemokine Reagents

View page
US Patent:
6812004, Nov 2, 2004
Filed:
Feb 10, 1997
Appl. No.:
08/799028
Inventors:
Christophe Caux - Lyons, FR
Serge J. E. Lebecque - Civrieux dAzergue, FR
Jacques Banchereau - Dallas TX
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C12N 1519
US Classification:
435 695, 435243, 4353201, 435 711, 435325, 530351, 536 235
Abstract:
A novel CC chemokine which is from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding said chemokine. Methods of using said reagents and diagnostic kits are also provided.

Adjuvants And Processes To Induce A Specific Type Of Immune Response

View page
US Patent:
6818221, Nov 16, 2004
Filed:
Jun 6, 2003
Appl. No.:
10/311123
Inventors:
Bali Pulendran - Atlanta GA
Jacques F. Banchereau - Dallas TX
Christopher W. Cutler - Stony Brook NY
Assignee:
Baylor Research Institute - Dallas TX
International Classification:
A61K 3902
US Classification:
4242341, 4242821
Abstract:
LPS elicits a Th2 immune response. LPS, detoxified LPS, derivatives of LPS, derivatives of detoxified LPS, Lipid A, detoxified Lipid A, derivatives of Lipid A, derivatives of detoxified Lipid A, or mimetics thereof, can be used as adjuvants to elicit a Th2 immune response, increase the efficacy of vaccinations in infectious diseases, decrease the severity of autoimmune responses, boost the Th2 immune response when needed in combination with the Th1 immune response, facilitate the industrial production of antibodies when used in animals, and study the Th2 immune response in laboratory animal research.

Methods For Treating Autoimmune Diseases In A Subject And In Vitro Diagnostic Assays

View page
US Patent:
7544357, Jun 9, 2009
Filed:
Jan 8, 2002
Appl. No.:
10/466023
Inventors:
Jacques F. Banchereau - Dallas TX, US
Anna Karolina Palucka - Dallas TX, US
Patrick Blanco - Talence, FR
Assignee:
Baylor Research Institute - Dallas TX
International Classification:
A61K 39/395
C12P 21/08
C07K 16/18
C07K 16/22
C07K 16/24
US Classification:
4241301, 4241311, 4241331, 4241361, 4241451, 5303871, 5303872, 5303881, 53038823, 53038824
Abstract:
The invention provides a method for treating an autoimmune disease in a subject by administering an interferon antagonist and a Flt3 ligand (Flt3L) antagonist. The invention also provides compositions containing one or more interferon antagonists, and one or more Flt3L antagonists, an in vitro assay for determining a subject's risk for developing an autoimmune disease, and kits for use, inter alia, with the assay.

Systemic Lupus Erythematosus Diagnostic Assay

View page
US Patent:
7608395, Oct 27, 2009
Filed:
Sep 15, 2005
Appl. No.:
11/228586
Inventors:
Maria Virginia Pascual - Dallas TX, US
Jacques F. Banchereau - Dallas TX, US
Lynda B. Bennett - Dallas TX, US
Assignee:
Baylor Research Institute - Dallas TX
International Classification:
C12Q 1/68
C12P 19/34
C07H 21/02
C07H 21/04
US Classification:
435 6, 435 71, 435 912, 536 235, 536 2431
Abstract:
The present invention provides compositions and methods for aiding in the diagnosis, monitoring and prognosis of SLE in a subject and for identifying potential therapeutic agents to treat and/or ameliorate the symptoms associated with SLE. Accordingly, embodiments of the invention are directed to methods of identifying the gene expression profile of a suitable sample by screening for the presence of a differentially expressed SLE-associated gene isolated from a sample containing or suspected of containing a cell that can differentially express an SLE-associated gene.

Compositions And Methods For The Systemic Treatment Of Arthritis

View page
US Patent:
7615212, Nov 10, 2009
Filed:
Feb 25, 2005
Appl. No.:
11/067335
Inventors:
Jacques Banchereau - Dallas TX, US
Virginia Pascual - Dallas TX, US
Assignee:
Baylor Research Institute - Dallas TX
International Classification:
A61K 39/395
A61K 38/20
US Classification:
4241301, 514 2, 514 12, 514825, 530351, 5303871, 5303891
Abstract:
The present invention includes compositions and methods for treating arthritic joints found in patients with autoinflammation, e. g. , systemic onset juvenile idiopathic arthritis, by administering at the site of inflammation a therapeutically effective amount of at least one agent that reduces or blocks the bioavailability of interleukin-1β.

Compositions And Methods For The Systemic Treatment Of Arthritis

View page
US Patent:
7622110, Nov 24, 2009
Filed:
Oct 26, 2007
Appl. No.:
11/925568
Inventors:
Jacques F. Banchereau - Dallas TX, US
Maria Virginia Pascual - Dallas TX, US
Assignee:
Baylor Research Institute - Dallas TX
International Classification:
A61K 39/395
A61K 38/20
C07K 14/545
C07K 14/715
US Classification:
4241301, 514 2, 514825, 530351, 5303871, 5303892
Abstract:
The present invention includes compositions and methods for treating arthritic joints found in patients with autoinflammation, e. g. , systemic onset juvenile idiopathic arthritis, by administering at the site of inflammation a therapeutically effective amount of at least one agent that reduces or blocks the bioavailability of interleukin-1β.

Anti-Interferon Alpha Monoclonal Antibodies And Methods For Use

View page
US Patent:
7888481, Feb 15, 2011
Filed:
Feb 6, 2009
Appl. No.:
12/367030
Inventors:
Jacques F. Banchereau - Dallas TX, US
Kiley Prilliman - Abilene TX, US
Virginia Pascual - Dallas TX, US
Anna Karolina Palucka - Dallas TX, US
Assignee:
Baylor Research Institute - Dallas TX
International Classification:
C07K 16/00
A61K 39/395
US Classification:
5303881, 4241301, 4241331
Abstract:
The present invention includes compositions and methods that include antibodies that selectively neutralize a bioactivity of at least two interferon alpha (“IFNα”) protein subtypes for the protein subtypes A, 2, B2, C, F, G, H2, I, J1, K, 4a, 4b and WA, but does not neutralize at least one bioactivity of IFNα protein subtype D. Examples of bioactivity for measurement include activation of the MxA promoter or antiviral activity and variants, derivatives and fragments thereof. The invention also includes host cells, hybridomas and plasmacytomas that produce antibodies. Because of their unique selectivity and affinity, the antibodies of the present invention are useful to detect IFNα subtypes in sample or tissue and/or for therapeutic applications that include, but are not limited to the treatment and/or amelioration of an IFNα related disorder such as SLE, lupus, type I diabetes, psoriasis, AIDS and Graft versus Host Disease.

Wikipedia References

Jacques Banchereau Photo 2

Jacques Banchereau

Control profile
Jacques F Banchereau from Montclair, NJ, age ~71 Get Report